Eton Pharmaceuticals (ETON) Other Accumulated Expenses (2023 - 2025)

Eton Pharmaceuticals has disclosed Other Accumulated Expenses across 3 years of filings, most recently posting $675000.0 for Q1 2025.

• In Q1 2025, Other Accumulated Expenses changed N/A year-over-year to $675000.0; the TTM figure through Mar 2025 stood at $675000.0 (changed N/A YoY), while the FY2023 annual figure was $5.4 million, changed N/A from the prior year.
• Other Accumulated Expenses came in at $675000.0 for Q1 2025 at Eton Pharmaceuticals, down from $4.9 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $5.4 million in Q4 2023 to a low of $675000.0 in Q1 2025.
• Average Other Accumulated Expenses over 3 years is $3.6 million, with a median of $4.9 million recorded in 2024.